Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients

Leonardo Calza (1) , Laura Mosca (1) , Daria Pocaterra (1) , Benedetta Piergentili (1) , Vincenzo Colangeli (1) , Roberto Manfredi (1) , Annalisa Erario (2) , Gabriele Grossi (2) , Gabriella Verucchi (1) , Pierluigi Viale (1)

1 Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, S.Orsola-Malpighi Hospital
2 Department of Haematology, Oncology and Laboratory Medicine, Central Laboratory, S.Orsola-Malpighi Hospital

Mots clés: Chronic hepatitis C; Antiretroviral therapy; Protease inhibitor; Pharmacokinetics; Therapeutic drug monitoring

Leonardo Calza, Laura Mosca, Daria Pocaterra, Benedetta Piergentili, Vincenzo Colangeli, et al.. Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients. European Journal of Clinical Pharmacology, 2010, 67 (2), pp.143-149. ⟨10.1007/s00228-010-0904-4⟩. ⟨hal-00627139⟩